r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

GS

Gary S. Stetz

Insider · Interim CEO · HEPA

Gary S. Stetz files insider transactions with the SEC as an interim ceo of Hepion Pharmaceuticals (HEPA). We hold 4 disclosed purchases and sales filed since 21 May 2012, 1 of them in the last 90 days.

  • Files forHEPA
  • Disclosed buys and sells4 in all, 1 in the last 90 days
  • Last disclosure12 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 21 April 2026 — 19 August 2026Interim CEO · Hepion Pharmaceuticals (HEPA)4 Form 4 lines · source: SEC Form 4
  • Filed 22 May 2026 — 26 May 2026Director · Canton Strategic Holdings (CNTN)8 Form 4 lines · source: SEC Form 4
  • Filed 3 November 2025 — 3 November 2025Director · Tharimmune (THAR)1 Form 4 line · source: SEC Form 4
  • Filed 18 May 2012 — 14 March 2018Director · Bcb Bancorp (BCBP)35 Form 4 lines · source: SEC Form 4

Everything they disclosed

48 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.